About cytarabine liposomal
Liposomal antimetabolite chemotherapy
Used for
- Treats lymphoma cells in cerebrospinal fluid (lymphomatous meningitis).
Usual adult dose
For lymphomatous meningitis: 50 mg injected into the cerebrospinal fluid every 14 days, usually for two doses; further dosing depends on response.
Common side effects
- Headache
- Nausea and vomiting
- Fever
- Confusion or seizures
Important warnings
- Administered into the spinal fluid by experienced clinicians; never inject into a vein.
- Can cause serious nervous-system damage, including seizures, weakness, or paralysis.
- Steroids are usually given to reduce inflammation of the spinal cord coverings.
- Requires monitoring of blood counts and neurological symptoms.
Pregnancy
May harm an unborn baby. Effective contraception is required during treatment and for six months afterward for women; three months for men.
Breastfeeding
Breastfeeding is not recommended during treatment and for one week after the last dose.
Interactions
- Other chemotherapy or radiation may increase nervous-system or bone-marrow toxicity.
- Medicines that affect the nervous system may complicate assessment of neurological side effects.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.